IRVINE, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC Pink: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its expansion plans are progressing rapidly as the final negotiations have been completed for the ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment